ArticleAlimentary pharmacology & therapeutics2025

Clinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver Disease.

Luis Antonio Diaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.